Necroptosis in Niemann–Pick disease, type C1: a potential therapeutic target

[1]  C. Ponting,et al.  High Incidence of Unrecognized Visceral/Neurological Late-onset Niemann-Pick Disease, type C1 Predicted by Analysis of Massively Parallel Sequencing Data Sets , 2015, Genetics in Medicine.

[2]  F. Platt,et al.  Improved neuroprotection using miglustat, curcumin and ibuprofen as a triple combination therapy in Niemann–Pick disease type C1 mice , 2014, Neurobiology of Disease.

[3]  R. Jaenisch,et al.  Genetic and Chemical Correction of Cholesterol Accumulation and Impaired Autophagy in Hepatic and Neural Cells Derived from Niemann-Pick Type C Patient-Specific iPS Cells , 2014, Stem cell reports.

[4]  W. Graier,et al.  Adaptations of Energy Metabolism Associated with Increased Levels of Mitochondrial Cholesterol in Niemann-Pick Type C1-deficient Cells* , 2014, The Journal of Biological Chemistry.

[5]  Mackenzie W. Mathis,et al.  Necroptosis Drives Motor Neuron Death in Models of Both Sporadic and Familial ALS , 2014, Neuron.

[6]  N. Faux,et al.  Altered transition metal homeostasis in Niemann-Pick disease, type C1. , 2014, Metallomics : integrated biometal science.

[7]  F. Platt,et al.  RIPK3 as a potential therapeutic target for Gaucher's disease , 2014, Nature Medicine.

[8]  P. Blank,et al.  Human and mouse neuroinflammation markers in Niemann-Pick disease, type C1 , 2014, Journal of Inherited Metabolic Disease.

[9]  R. Jaenisch,et al.  Impaired autophagy in the lipid-storage disorder Niemann-Pick type C1 disease. , 2013, Cell reports.

[10]  D. Watkins-Chow,et al.  Efficacy of N-acetylcysteine in phenotypic suppression of mouse models of Niemann-Pick disease, type C1. , 2013, Human molecular genetics.

[11]  Junying Yuan,et al.  A novel necroptosis inhibitor-necrostatin-21 and its SAR study. , 2013, Bioorganic & medicinal chemistry letters.

[12]  A. Degterev,et al.  Activity and specificity of necrostatin-1, small-molecule inhibitor of RIP1 kinase , 2012, Cell Death and Differentiation.

[13]  A. Lieberman,et al.  Impaired proteolysis underlies autophagic dysfunction in Niemann-Pick type C disease. , 2012, Human molecular genetics.

[14]  P. Vandenabeele,et al.  Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models , 2012, Cell Death and Disease.

[15]  O. Wiest,et al.  Quantitative Comparison of the Efficacy of Various Compounds in Lowering Intracellular Cholesterol Levels in Niemann-Pick Type C Fibroblasts , 2012, PloS one.

[16]  G. Prendergast,et al.  Amino acid catabolism: a pivotal regulator of innate and adaptive immunity , 2012, Immunological reviews.

[17]  Forbes D Porter,et al.  Microarray expression analysis and identification of serum biomarkers for Niemann-Pick disease, type C1. , 2012, Human molecular genetics.

[18]  R A Knight,et al.  Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012 , 2011, Cell Death and Differentiation.

[19]  Y. Zhang,et al.  Necrostatin-1 ameliorates symptoms in R6/2 transgenic mouse model of Huntington's disease , 2011, Cell Death and Disease.

[20]  Xingshun Xu,et al.  Synergistic protective effects of humanin and necrostatin-1 on hypoxia and ischemia/reperfusion injury , 2010, Brain Research.

[21]  Junying Yuan,et al.  Necroptosis as an alternative form of programmed cell death. , 2010, Current opinion in cell biology.

[22]  M. Patterson,et al.  Miglustat in adult and juvenile patients with Niemann-Pick disease type C: long-term data from a clinical trial. , 2010, Molecular genetics and metabolism.

[23]  D. Ory,et al.  Chronic Cyclodextrin Treatment of Murine Niemann-Pick C Disease Ameliorates Neuronal Cholesterol and Glycosphingolipid Storage and Disease Progression , 2009, PloS one.

[24]  W. Pavan,et al.  Linear clinical progression, independent of age of onset, in Niemann–Pick disease, type C , 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[25]  J. Repa,et al.  Reversal of defective lysosomal transport in NPC disease ameliorates liver dysfunction and neurodegeneration in the npc1−/− mouse , 2009, Proceedings of the National Academy of Sciences.

[26]  A. Galione,et al.  Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium , 2008, Nature Medicine.

[27]  M. Moskowitz,et al.  Necrostatin-1 Reduces Histopathology and Improves Functional Outcome after Controlled Cortical Impact in Mice , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[28]  Alexei Degterev,et al.  Identification of RIP1 kinase as a specific cellular target of necrostatins. , 2008, Nature chemical biology.

[29]  F. Ujjainwalla,et al.  Madin-Darby Canine Kidney II Cells: A Pharmacologically Validated System for NPC1L1-Mediated Cholesterol Uptake , 2008, Molecular Pharmacology.

[30]  M. Patterson,et al.  Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study , 2007, The Lancet Neurology.

[31]  R. Campenot,et al.  Inflammation in the Niemann‐Pick type‐C brain , 2007 .

[32]  A. Degterev,et al.  Structure-activity relationship analysis of a novel necroptosis inhibitor, Necrostatin-5. , 2007, Bioorganic & medicinal chemistry letters.

[33]  Y. Ioannou,et al.  Endosomal Accumulation of Toll-Like Receptor 4 Causes Constitutive Secretion of Cytokines and Activation of Signal Transducers and Activators of Transcription in Niemann–Pick Disease Type C (NPC) Fibroblasts: A Potential Basis for Glial Cell Activation in the NPC Brain , 2007, The Journal of Neuroscience.

[34]  Alexei Degterev,et al.  Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury , 2005, Nature chemical biology.

[35]  J. Lee,et al.  Glial cell line-derived neurotrophic factor is essential for neuronal survival in the locus coeruleus–hippocampal noradrenergic pathway , 2004, Neuroscience.

[36]  S. Walkley,et al.  Consequences of NPC1 and NPC2 loss of function in mammalian neurons. , 2004, Biochimica et biophysica acta.

[37]  R. Dwek,et al.  Accumulation of Glycosphingolipids in Niemann-Pick C Disease Disrupts Endosomal Transport* , 2004, Journal of Biological Chemistry.

[38]  A. Granholm,et al.  Minocycline protects basal forebrain cholinergic neurons from mu p75‐saporin immunotoxic lesioning , 2004, The European journal of neuroscience.

[39]  S. Ohara,et al.  Axonal dystrophy of dorsal root ganglion sensory neurons in a mouse model of Niemann–Pick disease type C , 2004, Experimental Neurology.

[40]  O. Bernard,et al.  Studies on neuronal death in the mouse model of Niemann‐Pick C disease , 2002, Journal of neuroscience research.

[41]  S. Walkley,et al.  Critical role for glycosphingolipids in Niemann-Pick disease type C , 2001, Current Biology.

[42]  D. German,et al.  Selective neurodegeneration, without neurofibrillary tangles, in a mouse model of Niemann‐Pick C disease , 2001, The Journal of comparative neurology.

[43]  R. Brady,et al.  Localization of Niemann-Pick C1 protein in astrocytes: implications for neuronal degeneration in Niemann- Pick type C disease. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[44]  W. Pavan,et al.  Murine model of Niemann-Pick C disease: mutation in a cholesterol homeostasis gene. , 1997, Science.

[45]  T. Vanden Berghe,et al.  Programmed necrosis from molecules to health and disease. , 2011, International review of cell and molecular biology.

[46]  A. Degterev,et al.  Structure-activity relationship study of a novel necroptosis inhibitor, necrostatin-7. , 2008, Bioorganic & medicinal chemistry letters.

[47]  G. Weissmann.  Americans sweep Nobel Prizes: thinking inside and outside the box. , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[48]  R. Proia,et al.  Apoptosis accompanied by up-regulation of TNF-alpha death pathway genes in the brain of Niemann-Pick type C disease. , 2005, Molecular genetics and metabolism.

[49]  S. Murayama,et al.  Cerebellar degeneration in the Niemann-Pick type C mouse , 2004, Acta Neuropathologica.